Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00473161

Enrollment

Registered

2007-05-14

Start date

2007-05-31

Completion date

Unknown

Last updated

2014-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Hypertonia, Weakness

Keywords

movement disorders, childhood

Brief summary

A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.

Detailed description

Children ages newborn to 21 with a diagnosis of arm weakness, hypertonia, or hyperkinesia due to cerebral palsy will be recruited. A muscle that is either over-active or under-active will be selected for each child. The child will be provided with the device to wear for 1 month in order to call attention to the identified muscle. At the beginning and end of the month, reaching will be assessed using three-dimensional kinematic motion capture. The outcome measure will be the speed and curvature of reaching to a target in front of the child.

Interventions

DEVICEsurface EMG biofeedback

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to 21 Years

Healthy volunteers

Inclusion criteria

* weakness, hypertonia, or hyperkinetic disorder affecting one or both arms * reduced speed or quality of reaching

Exclusion criteria

* any condition that would increase the risk of participation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026